Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Egan

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Future Microbiology|March 29, 2013
Dual-functioning antimalarials that inhibit the chloroquine-resistance transporterTimothy J Egan, David Kuter
Trends in Parasitology|February 19, 2002
Pigment biocrystallization in Plasmodium falciparumErnst Hempelmann, Timothy J Egan
Journal of Inorganic Biochemistry|December 9, 2003
Effects of solvent composition and ionic strength on the interaction of quinoline antimalarials with ferriprotoporphyrin IXTimothy J Egan, Kanyile K Ncokazi
Current Topics in Medicinal Chemistry|January 28, 2020
Quinoline Containing Side-chain Antimalarial Analogs: Recent Advances and Therapeutic ApplicationMukesh C Joshi, Timothy J Egan
Analytical Biochemistry|March 5, 2005
A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compoundsKanyile K Ncokazi, Timothy J Egan
Dalton Transactions (Cambridge, England : 2003)|October 25, 2006
Kinetics of beta-haematin formation from suspensions of haematin in aqueous benzoic acidTimothy J Egan, Mmboneni G Tshivhase
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 21, 2004
Porcine small intestine submucosa for soft tissue augmentationJeffrey H Spiegel, Timothy J Egan
Journal of Inorganic Biochemistry|June 2, 2005
Quinoline antimalarials decrease the rate of beta-hematin formationTimothy J Egan, Kanyile K Ncokazi
Current Opinion in Infectious Diseases|November 3, 2007
Strategies to reverse drug resistance in malariaTimothy J Egan, Catherine H Kaschula
Current Opinion in Pharmacology|September 29, 2018
Editorial overview: Tuberculosis, malaria and schistosomiasis; understanding resistance and development of new drugsTimothy J Egan, Digby F Warner
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Future Microbiology|March 29, 2013
Dual-functioning antimalarials that inhibit the chloroquine-resistance transporterTimothy J Egan, David Kuter
Trends in Parasitology|February 19, 2002
Pigment biocrystallization in Plasmodium falciparumErnst Hempelmann, Timothy J Egan
Journal of Inorganic Biochemistry|December 9, 2003
Effects of solvent composition and ionic strength on the interaction of quinoline antimalarials with ferriprotoporphyrin IXTimothy J Egan, Kanyile K Ncokazi
Current Topics in Medicinal Chemistry|January 28, 2020
Quinoline Containing Side-chain Antimalarial Analogs: Recent Advances and Therapeutic ApplicationMukesh C Joshi, Timothy J Egan
Analytical Biochemistry|March 5, 2005
A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compoundsKanyile K Ncokazi, Timothy J Egan
Dalton Transactions (Cambridge, England : 2003)|October 25, 2006
Kinetics of beta-haematin formation from suspensions of haematin in aqueous benzoic acidTimothy J Egan, Mmboneni G Tshivhase
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|December 21, 2004
Porcine small intestine submucosa for soft tissue augmentationJeffrey H Spiegel, Timothy J Egan
Journal of Inorganic Biochemistry|June 2, 2005
Quinoline antimalarials decrease the rate of beta-hematin formationTimothy J Egan, Kanyile K Ncokazi
Current Opinion in Infectious Diseases|November 3, 2007
Strategies to reverse drug resistance in malariaTimothy J Egan, Catherine H Kaschula
Current Opinion in Pharmacology|September 29, 2018
Editorial overview: Tuberculosis, malaria and schistosomiasis; understanding resistance and development of new drugsTimothy J Egan, Digby F Warner
Pageof 12